GlassScriptPhysician profile
Syed Arshadm Hassan
NPI 1710935879
$1,259.47
in general payments reported to CMS, 2019-2025
17 companies · $348 in 2025
The $348 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2021: $218 · 2022: $276 · 2023: $84.87 · 2024: $99.74 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $515 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $515.44 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $424.95 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $133.02 | 2024-2025 | Airsupra, Breztri |
| Gilead Sciences, INC. | $121.21 | 2019 | |
| Celonova Biosciences, INC. | $111.74 | 2019 | |
| Glaxosmithkline, LLC. | $88.35 | 2022-2025 | Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $82.63 | 2023-2025 | |
| Amgen INC. | $72.69 | 2025 | Otezla, Repatha |
| Novo Nordisk INC | $34.03 | 2025 | Ozempic |
| Exact Sciences Corporation | $33.21 | 2025 | Cologuard Collection Kit |
| Insmed, INC. | $31.45 | 2025 | Brinsupri |
| Photonicare INC | $26.56 | 2023 | Otosight Middle Ear Scope |
| Corcept Therapeutics | $21.36 | 2025 | Korlym |
| Pfizer INC. | $17.00 | 2022 | |
| Currax Pharmaceuticals LLC | $16.35 | 2025 | Contrave |
| Abbvie INC. | $15.87 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $15.52 | 2024 | Mounjaro, Zepbound |
| Axonics, INC. | $13.53 | 2024 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Hassan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.